Eversheds has been appointed as legal adviser to the Cell Therapy Catapult, a UK centre of excellence in cell therapy, following a competitive pitch process. The law firm’s appointment will cover all aspects of the Cell Therapy Catapult’s operations, including intellectual property and life sciences issues, procurement and state aid, HR, real estate and construction. […]
Eversheds has advised Allied Glass on a tertiary buyout backed by CBPE Capital. Allied Glass is one of the largest glass manufacturers in the UK, manufacturing glass containers for the spirits industry. The Eversheds team was led by corporate partner Robin Skelton, assisted by senior associate David Milne and associate Carly Gulliver.
Walker Morris has presented 50 children with prizes at a special presentation ceremony at its offices on 9 November, for its 19th annual Children’s Charity Calendar Painting Competition. The 13 winners, one for each month of the year, plus the front page, were all presented with a hamper full of artists’ materials worth £50, plus […]
Conyers Dill & Pearman has advised International Housewares Retail Company regarding its HKD600m (£50m) listing on the main board of the Hong Kong Stock Exchange by way of Hong Kong public offer and international placing. Anna Chong of Conyers’ Hong Kong office provided Cayman advice to the company. Conyers worked alongside Woo, Kwan, Lee & Lo, […]
The international arbitration team at Eversheds has successfully represented the government of Cambodia in the International Court of Justice (ICJ), in relation to a case brought by Cambodia against Thailand concerning the interpretation of the court’s 1962 judgment in the case concerning the Temple of Preah Vihear. The ICJ ruled that Thailand is obliged to […]
Following a review by former president of the European Investment Bank Philippe Maystadt, new recommendations for enhancing the EU’s role in international accounting standard setting are due to be presented to EU finance ministers on 15 November 2013. Eversheds has commented ahead of the presentation of these recommendations. Michael Wainwright, partner and financial regulation expert […]
After months of wrangling, European politicians have now reached an agreement on the implementation of Solvency II. Eversheds believes that the deal will bring relief to the insurance industry. Jeremy Irving, partner and insurance expert at the law firm, said: ‘The EU’s failure to implement Solvency II in accordance with its original timetable had left […]
The Dublin office of Eversheds has advised on the takeover by Endo Health Solutions of Paladin Labs Europe for approximately $1.7bn (£1.1bn). The acquiring entity will be an Irish holding company. The deal is the first Irish inversion with no primary Irish target. An inversion is a legal transaction whereby one corporation becomes a subsidiary […]
The Court of Appeal judgment in Kavanagh v Crystal Palace FC (2000), in which Walker Morris acted for the successful appellant, the purchaser of a business out of administration, determined an important issue involving the interaction of the law concerning the position of employees on the transfer of the undertakings of their employer and the regime governing […]
By Alec Christie and Rose Bollard The Australian Prudential Regulation Authority (APRA) has issued the final version of its new prudential practice guide, Prudential Practice Guide CPG 235 — Managing Data Risk. The data guide aims to assist financial institutions, general and life insurance companies and superannuation funds regulated by APRA to manage their data […]
By Dianne LaRocca Much has been written following the Supreme Court’s decisions in AT&T Mobility LLC v Concepcion, Oxford Health Plans, LLC v Sutter and American Express Co v Italian Colors Restaurant. Yet, in this crowded field, there is a need for clear thinking on the most pragmatic issues: deciding whether to adopt arbitration and, if so, how to draft […]
By Katharine Liao Despite 20 states allowing the use of medicinal marijuana and two more — Colorado and Washington — allowing recreational marijuana use, employers remain unaffected. Courts consistently find that employers may terminate employees who test positive for marijuana, regardless of whether such employees are using marijuana to treat a disability; whether they were not […]